Prescription Opioid Distribution after the Legalization of Recreational Marijuana in Colorado Amalie K. Kropp Lopez, Stephanie D. Nichols, Daniel Y. Chung, Daniel E. Kaufman, Kenneth L. McCall and Brian J. Piper International Journal of Environmental Research and Public Health, 2020, 17, 3251 doi : 10.3390/ijerph17093251 Abstract : There have been dynamic changes in prescription opioid use in the US but the state level policy factors contributing to these are incompletely understood. We examined the association between the legalization of recreational marijuana and prescription opioid distribution in Colorado. Utah and Maryland, two states that had not legalized recreational marijuana, were selected for comparison. Prescription data reported to [...]
Lire la suite5 Ways Quarantine Has Changed the Cannabis Industry Forever Covid-19 lockdown sparks a 'green rush,' changing how consumers shop By T.L. Stanley | May 5, 2020 https://www.adweek.com/digital/5-ways-quarantine-has-changed-the-cannabis-industry-forever/ As cannabis brands emerge from months in quarantine, how will they be changed by the experience? Key insights: New shopping methods aren't just a crisis response. They're also super convenient. Move over, brownies. Demand for next-gen edibles and infused products is skyrocketing. Budget tightening? Meet the new value brands of cannabis. Stuck in quarantine for weeks on end and hoarding necessities, consumers have made their Covid-19 buying preferences extremely clear: toilet paper, frozen pizza, jigsaw puzzles and hand sanitizer. For certain consumers, [...]
Lire la suiteEtats-Unis : l’Epidiolex n’est plus une substance contrôlée Aurélien BERNARD Newsweed.fr, 8 avril 2020 https://www.newsweed.fr/etats-unis-lepidiolex-nest-plus-une-substance-controlee/ GW Pharmaceuticals a annoncé lundi que l’Epidiolex, un médicament à base de cannabidiol (CBD) utilisé dans le traitement de l’épilepsie, avait été retiré de l’annexe V de la Loi américaine sur les substances contrôlées par la Drug Enforcement Administration (DEA). Les personnes qui pourraient en bénéficier pourront dorénavant en obtenir plus facilement. GW a déclaré dans son communiqué qu’il « entamera maintenant le processus de mise en œuvre de ces changements au niveau de l’État et via le réseau de distribution EPIDIOLEX ». Comme pour de nombreux médicaments non-contrôlés, les malades ou leurs [...]
Lire la suiteThe Consciousness Research of Stanislav Grof : A Cosmic Portal Beyond Individuality By Richard Yensen, Ph.D. and Donna A. Dryer, M.D., M.P.H. ©1998 Richard Yensen & Donna Dryer I. Introduction Stanislav Grof began his research in Prague, Czechoslovakia, as a psychiatric resident, in the late 1950’s. His initial observations seemed to confirm and offer a laboratory proof for many of the basic tenets of Freudian psychoanalytic thought. At that time his conclusion was politically unsettling because psychoanalysis was repressed in the iron curtain countries. Forty years later the outcome of Grof’s continued research is a theoretical framework for understanding human consciousness. His theory has [...]
Lire la suiteSan Francisco et New York classent la vente de weed comme « service essentiel » durant l’épidémie Accueil » A l'international » PrincipesActifs.org, Publié le 21 Mars 2020 https://www.principesactifs.org/san-francisco-et-new-york-classent-la-vente-de-weed-comme-service-essentiel-durant-lepidemie/ Alors que les commerces ferment les uns après les autres aux États-Unis pour endiguer la pandémie de coronavirus (Covid-19), certains États et certaines Villes américaines ont classé les boutiques de cannabis parmi les « services essentiels ». Elles pourront donc rester ouvertes malgré les mesures de confinement, rapportait la radio publique NPR mercredi 18 mars. La Ville de San Francisco exige que ses habitants restent chez eux, à moins qu’ils fournissent un « service essentiel [...]
Lire la suiteWhere Is Marijuana Legal in the US? [2020] https://www.testclear.com/Where-Is-Marijuana-Legal-in-the-US-2020.aspx Marijuana continues to tread between legal and illegal status, depending on where you are looking in the US and for what purpose you are using the substance. Where Is Marijuana Legal? Medical Marijuana Recreational Marijuana Decriminalized THC-low, CBD-High Allowed Table of Contents Where Is Marijuana Legal? Where Is Marijuana Decriminalized? What Are State Marijuana Laws? What Is the Impact of Marijuana Legalization? What Is the Cole Memorandum? Is Marijuana Legal at the Federal Level? What’s Next for the Legalization of Marijuana? Where Does the Public Stand on Marijuana? What Can You Do? As far as the [...]
Lire la suiteThe current state and future perspectives of cannabinoids in cancer biology Paweł Śledziński, Joanna Zeyland, Ryszard Słomski & Agnieszka Nowak Cancer Medicine, 2018, 7, (3), 765–775. doi : 10.1002/cam4.1312 Abstract To date, cannabinoids have been allowed in the palliative medicine due to their analgesic and antiemetic effects, but increasing number of preclinical studies indicates their anticancer properties. Cannabinoids exhibit their action by a modulation of the signaling pathways crucial in the control of cell proliferation and survival. Many in vitro and in vivo experiments have shown that cannabinoids inhibit proliferation of cancer cells, stimulate autophagy and apoptosis, and have also a potential to inhibit angiogenesis [...]
Lire la suiteStroke in young cannabis users (18-49 years) : National trends in hospitalizations and outcomes Rupak Desai, Sandeep Singh, Krupa Patel, Hemant Goyal, Manan Shah, Zeeshan Mansuri, Smit Patel, Zabeen K Mahuwala, Larry B Goldstein and Adnan I Qureshi International Journal of Stroke, 2019, doi: 10.1177/1747493019895651 Abstract BACKGROUND : Recent legalization of therapeutic and recreational cannabis use makes it imperative to have an insight into odds and trends in young-onset stroke-related hospitalizations among cannabis users (18-49 years). METHODS : The National Inpatient Sample dataset (2007-2014) was utilized to assess national trends, odds of young-onset stroke-related hospitalizations, and outcomes among cannabis users vs. nonusers using provided discharge weights, [...]
Lire la suiteCOMMENTARY A Physician's Guide to the Cannabidiol Craze Angela Coombs, MD; Diana M. Martinez, MD Medscape, May 31, 2019 Last month at the Columbia University Department of Psychiatry in upper Manhattan, Columbia chief psychiatry resident Dr Angela Coombs interviewed addiction expert Dr Diana Martinez on a number of issues related to the rising popularity and usage of cannabidiol (CBD). This transcript has been edited for clarity. Angela Coombs, MD: Hi. My name is Dr Angela Coombs and I'm a chief resident here at Columbia. We are so happy to be able to have Dr Diana Martinez, who's a professor in psychiatry at Columbia and an expert [...]
Lire la suiteAre Your Patients Taking CBD? - Medscape - January 15, 2020 https://www.medscape.com/viewarticle/923801 Cannabidiol (CBD) is having its moment in the sun. A Gallup poll from last August found that 1 in 7 Americans use CBD, that 11% of users are 50 to 64 years of age, and that 8% are at least 65 years of age. Pain relief, anxiety, insomnia, and arthritis are the top reasons for use. Nearly 4 in 10 Americans think CBD oils should be legally available for adults to buy over the counter. Although the 2018 Farm Bill removed hemp (cannabis and cannabis derivatives such as CBD that contain less than 0.3% THC) [...]
Lire la suite